MHLW Approves Pfizer's Zithromax Slow Release Drug
This article was originally published in PharmAsia News
Executive Summary
The second division on new drugs of the Pharmaceutical Affairs and Food Sanitation Council at Japan's Ministry of Health, Labor and Welfare approved Pfizer's slow-release Zithromax (azithromycin) for adult use. It is indicated to treat bacterial infection such as gonococcal infection. The re-examination period is four years. The slow release version of azithromycin allows one dose use to last for three days. (Click here for more - Japanese language